BI 853520

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 853520, covering 2014-09-04 to 2015-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer [Phase 1]